UBS Group’s TNL Mediagene TNMG Stock Holding History

UBS Group’s Portfolio TNMG Stock Details TNMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.09K	Sell	1,134 -2,000	-64%	-$5.56K	﹤0.01%	9363
2025 Q4	$8.56K	Buy	3,134 +2,761	+740%	+$16.1K	﹤0.01%	8355
2025 Q3	$1.98K	Sell	373 -1,804	-83%	-$14.7K	﹤0.01%	9247
2025 Q2	$21.3K	Buy	2,177 +2,014	+1,236%	+$21.5K	﹤0.01%	8382
2025 Q1	$2.48K	Buy	163 +47	+41%	+$2.39K	﹤0.01%	9324
2024 Q4	$18.4K	Buy	+116	New	+$22.3K	﹤0.01%	7932

UBS Group's TNMG Position: Q1 2026 in Review

UBS Group reduced its TNL Mediagene (TNMG) stake by 64% in Q1 2026, selling an estimated $5.56K and leaving 1,134 shares worth $2.09K. The position accounts for ﹤0.01% of the portfolio, ranked #9363.

UBS Group first reported a position in TNMG in Q4 2024 and has held it in 6 quarters since. The position peaked at $21.3K in Q2 2025. 1 fund tracked by Wall St. Rank holds TNMG as of Q1 2026.

UBS Group held 1,134 shares of TNL Mediagene worth $2.09K as of Q1 2026.
UBS Group sold 2,000 TNL Mediagene shares in Q1 2026, an estimated $5.56K.
TNL Mediagene made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9363 holding.
UBS Group first reported a position in TNL Mediagene in Q4 2024 and has held it in 6 quarters since.
UBS Group's TNL Mediagene position peaked at $21.3K in Q2 2025.
1 fund tracked by Wall St. Rank held TNL Mediagene as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.